Drug class in one race
KAT6A / KAT6B drugs for HR+/HER2- Metastatic Breast Cancer
3 tracked KAT6A / KAT6B drugs in the HR+/HER2- Metastatic Breast Cancer race. The class explanation lives on the KAT6A / KAT6B page; the full indication pipeline across every mechanism is on the HR+/HER2- Metastatic Breast Cancer page.
1 Phase 31 Phase 1/21 Phase 1